Incidence of unexpected significant pathology in morcellated uterine specimens

Sherine Salama; Nadia Ismiil; Matthew Cesari; Fang-I Lu; Elzbieta Slodkowska; Valerie Dubé; Guangming Han; Mark Marcus; Ivy Heung; Mahmoud A Khalifa; Lilian T Gien; Sharon Nofech-Mozes*

    Study objective: To determine the frequency and outcome of significant pathology in morcellated hysterectomy and myomectomy specimens and to provide a detailed pathologic account on its relative clinical safety.
Design: This is a retrospective audit of morcellated uterine specimens where preoperative, operative, pathology, adjuvant therapy (when available) and follow up data were collected. Overt malignancy and high risk pathology cases were further analyzed.